Original Investigation
Editorial Comment
Lowering the Thresholds of Diseases: Is Anyone Still Healthy?∗

https://doi.org/10.1016/j.jacc.2017.11.029Get rights and content
Under an Elsevier user license
open archive

Key Words

antihypertensive therapy
blood pressure target
hypertension
hypertension guidelines
prevalence

Cited by (0)

Dr. Messerli is a consultant or advisor for the American College of Cardiology, Daiichi-Sankyo, Pfizer, Abbott, Servier, Medtronic, WebMD, Menarini, Ipca, and Hikma. Dr. Bangalore is a consultant or advisor for Daiichi-Sankyo, Pfizer, Abbott, Merck, Boerhinger-Ingelheim, Gilead, and Abbott Vascular.

∗

Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

© 2018 by the American College of Cardiology Foundation. Published by Elsevier.